COMMUNIQUÉS West-GlobeNewswire

-
Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
22/04/2025 - 15:05 -
Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa
22/04/2025 - 15:05 -
Cambridge’s DIOSynVax and Singapore’s ACM Biolabs to Advance Pandemic-Ready Universal Bird Flu Vaccine with International Support
22/04/2025 - 15:07 -
NFL Hall of Famer John Randle Tackles Joint Stiffness with New Supplement Partner Campio
22/04/2025 - 15:09 -
Nashville-based Healthcare Consulting Group, FKP Advisors, joins the Board of Directors of Healthcare Integrated Technologies Inc.
22/04/2025 - 15:15 -
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
22/04/2025 - 15:20 -
NewGen Filed 2024 Annual Report on Form 20-F
22/04/2025 - 15:26 -
Konica Minolta Healthcare Partners with openDoctor to Deliver Best-in-Class Patient Engagement
22/04/2025 - 15:36 -
U.S. Oral Surgery Management Announces Partnership with Douglas J. Valentine DDS Oral & Maxillofacial Surgery
22/04/2025 - 15:45 -
Oncotelic CEO Vuong Trieu to Present Innovative "Deciparticles" Platform at IDDST-Europe 2025 Conference in Stockholm
22/04/2025 - 16:00 -
Andrew Taylor joins Novonesis’ Executive Leadership Team
22/04/2025 - 17:00 -
CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA
22/04/2025 - 11:16 -
Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025
22/04/2025 - 11:30 -
Prime Biome Reviews 2025: Updated Comprehensive Guide to the Revolutionary Gut & Skin Health Supplement!
22/04/2025 - 11:33 -
PrimeBiome Reviews: “Gut–Skin Miracle” or Just Hype? Expert Insights
22/04/2025 - 11:42 -
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
22/04/2025 - 12:00 -
AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025
22/04/2025 - 12:00 -
R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDE® Drug Eluting Bioresorbable Scaffold
22/04/2025 - 12:00 -
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
22/04/2025 - 12:45
Pages